Home > > > Report Detail

Covid-19 Impact on Global Pharmacovigilance (PV) Outsourcing Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 12-May-2020
No. of pages: 128
Inquire Before Buying

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmacovigilance (PV) Outsourcing market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Pharmacovigilance (PV) Outsourcing industry.

Based on our recent survey, we have several different scenarios about the Pharmacovigilance (PV) Outsourcing YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Pharmacovigilance (PV) Outsourcing will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacovigilance (PV) Outsourcing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacovigilance (PV) Outsourcing market in terms of revenue.

Players, stakeholders, and other participants in the global Pharmacovigilance (PV) Outsourcing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Pharmacovigilance (PV) Outsourcing market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Pharmacovigilance (PV) Outsourcing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacovigilance (PV) Outsourcing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacovigilance (PV) Outsourcing market.

The following players are covered in this report:

- Accenture

- C3i Solutions

- Clintec

- Covance

- Deloitte Touche Tohmatsu Limited

- ELC Group

- Ergomed

- iGATE Corporation

- iMED Global Corporation

- IQVIA

- MarksMan Healthcare

- Medpace Holdings

- Novartis

- Oracle Corporation

- Parexel

- PharmInvent

- PrimeVigilance

- Pure Drug Safety

- Sciformix

- SIRO Clinpharm

- Symogen

Pharmacovigilance (PV) Outsourcing Breakdown Data by Type

- Contract Research Organizations (CROs)

- Business Process Outsourcing (BPOs)

Pharmacovigilance (PV) Outsourcing Breakdown Data by Application

- Premarketing Clinical Trial

- Post-marketing Clinical Practice

- Other

Covid-19 Impact on Global Pharmacovigilance (PV) Outsourcing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Contract Research Organizations (CROs)
1.4.3 Business Process Outsourcing (BPOs)
1.5 Market by Application
1.5.1 Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2020 VS 2026
1.5.2 Premarketing Clinical Trial
1.5.3 Post-marketing Clinical Practice
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Pharmacovigilance (PV) Outsourcing Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmacovigilance (PV) Outsourcing Industry
1.6.1.1 Pharmacovigilance (PV) Outsourcing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmacovigilance (PV) Outsourcing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmacovigilance (PV) Outsourcing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Pharmacovigilance (PV) Outsourcing Market Perspective (2015-2026)
2.2 Pharmacovigilance (PV) Outsourcing Growth Trends by Regions
2.2.1 Pharmacovigilance (PV) Outsourcing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Share by Regions (2015-2020)
2.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Pharmacovigilance (PV) Outsourcing Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmacovigilance (PV) Outsourcing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Market Size
3.1.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue (2015-2020)
3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio
3.2.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2019
3.3 Pharmacovigilance (PV) Outsourcing Key Players Head office and Area Served
3.4 Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
3.5 Date of Enter into Pharmacovigilance (PV) Outsourcing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2015-2020)
4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2021-2026)
5 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application (2015-2026)
5.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020)
5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2015-2020)
6.2 Pharmacovigilance (PV) Outsourcing Key Players in North America (2019-2020)
6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020)
6.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2015-2020)
7.2 Pharmacovigilance (PV) Outsourcing Key Players in Europe (2019-2020)
7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020)
7.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020)
8 China
8.1 China Pharmacovigilance (PV) Outsourcing Market Size (2015-2020)
8.2 Pharmacovigilance (PV) Outsourcing Key Players in China (2019-2020)
8.3 China Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020)
8.4 China Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pharmacovigilance (PV) Outsourcing Market Size (2015-2020)
9.2 Pharmacovigilance (PV) Outsourcing Key Players in Japan (2019-2020)
9.3 Japan Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020)
9.4 Japan Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size (2015-2020)
10.2 Pharmacovigilance (PV) Outsourcing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020)
11 India
11.1 India Pharmacovigilance (PV) Outsourcing Market Size (2015-2020)
11.2 Pharmacovigilance (PV) Outsourcing Key Players in India (2019-2020)
11.3 India Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020)
11.4 India Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pharmacovigilance (PV) Outsourcing Market Size (2015-2020)
12.2 Pharmacovigilance (PV) Outsourcing Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020)
12.4 Central & South America Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Accenture
13.1.1 Accenture Company Details
13.1.2 Accenture Business Overview and Its Total Revenue
13.1.3 Accenture Pharmacovigilance (PV) Outsourcing Introduction
13.1.4 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020))
13.1.5 Accenture Recent Development
13.2 C3i Solutions
13.2.1 C3i Solutions Company Details
13.2.2 C3i Solutions Business Overview and Its Total Revenue
13.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Introduction
13.2.4 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.2.5 C3i Solutions Recent Development
13.3 Clintec
13.3.1 Clintec Company Details
13.3.2 Clintec Business Overview and Its Total Revenue
13.3.3 Clintec Pharmacovigilance (PV) Outsourcing Introduction
13.3.4 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.3.5 Clintec Recent Development
13.4 Covance
13.4.1 Covance Company Details
13.4.2 Covance Business Overview and Its Total Revenue
13.4.3 Covance Pharmacovigilance (PV) Outsourcing Introduction
13.4.4 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.4.5 Covance Recent Development
13.5 Deloitte Touche Tohmatsu Limited
13.5.1 Deloitte Touche Tohmatsu Limited Company Details
13.5.2 Deloitte Touche Tohmatsu Limited Business Overview and Its Total Revenue
13.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Introduction
13.5.4 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.5.5 Deloitte Touche Tohmatsu Limited Recent Development
13.6 ELC Group
13.6.1 ELC Group Company Details
13.6.2 ELC Group Business Overview and Its Total Revenue
13.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Introduction
13.6.4 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.6.5 ELC Group Recent Development
13.7 Ergomed
13.7.1 Ergomed Company Details
13.7.2 Ergomed Business Overview and Its Total Revenue
13.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Introduction
13.7.4 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.7.5 Ergomed Recent Development
13.8 iGATE Corporation
13.8.1 iGATE Corporation Company Details
13.8.2 iGATE Corporation Business Overview and Its Total Revenue
13.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Introduction
13.8.4 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.8.5 iGATE Corporation Recent Development
13.9 iMED Global Corporation
13.9.1 iMED Global Corporation Company Details
13.9.2 iMED Global Corporation Business Overview and Its Total Revenue
13.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Introduction
13.9.4 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.9.5 iMED Global Corporation Recent Development
13.10 IQVIA
13.10.1 IQVIA Company Details
13.10.2 IQVIA Business Overview and Its Total Revenue
13.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Introduction
13.10.4 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
13.10.5 IQVIA Recent Development
13.11 MarksMan Healthcare
10.11.1 MarksMan Healthcare Company Details
10.11.2 MarksMan Healthcare Business Overview and Its Total Revenue
10.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Introduction
10.11.4 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.11.5 MarksMan Healthcare Recent Development
13.12 Medpace Holdings
10.12.1 Medpace Holdings Company Details
10.12.2 Medpace Holdings Business Overview and Its Total Revenue
10.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Introduction
10.12.4 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.12.5 Medpace Holdings Recent Development
13.13 Novartis
10.13.1 Novartis Company Details
10.13.2 Novartis Business Overview and Its Total Revenue
10.13.3 Novartis Pharmacovigilance (PV) Outsourcing Introduction
10.13.4 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.13.5 Novartis Recent Development
13.14 Oracle Corporation
10.14.1 Oracle Corporation Company Details
10.14.2 Oracle Corporation Business Overview and Its Total Revenue
10.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Introduction
10.14.4 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.14.5 Oracle Corporation Recent Development
13.15 Parexel
10.15.1 Parexel Company Details
10.15.2 Parexel Business Overview and Its Total Revenue
10.15.3 Parexel Pharmacovigilance (PV) Outsourcing Introduction
10.15.4 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.15.5 Parexel Recent Development
13.16 PharmInvent
10.16.1 PharmInvent Company Details
10.16.2 PharmInvent Business Overview and Its Total Revenue
10.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Introduction
10.16.4 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.16.5 PharmInvent Recent Development
13.17 PrimeVigilance
10.17.1 PrimeVigilance Company Details
10.17.2 PrimeVigilance Business Overview and Its Total Revenue
10.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Introduction
10.17.4 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.17.5 PrimeVigilance Recent Development
13.18 Pure Drug Safety
10.18.1 Pure Drug Safety Company Details
10.18.2 Pure Drug Safety Business Overview and Its Total Revenue
10.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Introduction
10.18.4 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.18.5 Pure Drug Safety Recent Development
13.19 Sciformix
10.19.1 Sciformix Company Details
10.19.2 Sciformix Business Overview and Its Total Revenue
10.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Introduction
10.19.4 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.19.5 Sciformix Recent Development
13.20 SIRO Clinpharm
10.20.1 SIRO Clinpharm Company Details
10.20.2 SIRO Clinpharm Business Overview and Its Total Revenue
10.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Introduction
10.20.4 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.20.5 SIRO Clinpharm Recent Development
13.21 Symogen
10.21.1 Symogen Company Details
10.21.2 Symogen Business Overview and Its Total Revenue
10.21.3 Symogen Pharmacovigilance (PV) Outsourcing Introduction
10.21.4 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
10.21.5 Symogen Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Pharmacovigilance (PV) Outsourcing Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue
Table 3. Ranking of Global Top Pharmacovigilance (PV) Outsourcing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Contract Research Organizations (CROs)
Table 6. Key Players of Business Process Outsourcing (BPOs)
Table 7. COVID-19 Impact Global Market: (Four Pharmacovigilance (PV) Outsourcing Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pharmacovigilance (PV) Outsourcing Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pharmacovigilance (PV) Outsourcing Players to Combat Covid-19 Impact
Table 12. Global Pharmacovigilance (PV) Outsourcing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Pharmacovigilance (PV) Outsourcing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Pharmacovigilance (PV) Outsourcing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions (2015-2020)
Table 16. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Pharmacovigilance (PV) Outsourcing Market Growth Strategy
Table 22. Main Points Interviewed from Key Pharmacovigilance (PV) Outsourcing Players
Table 23. Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2015-2020) (Million US$)
Table 24. Global Pharmacovigilance (PV) Outsourcing Market Share by Players (2015-2020)
Table 25. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2019)
Table 26. Global Pharmacovigilance (PV) Outsourcing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
Table 29. Date of Enter into Pharmacovigilance (PV) Outsourcing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 32. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Type (2015-2020)
Table 33. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2021-2026)
Table 34. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2015-2020)
Table 35. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 36. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2021-2026)
Table 37. North America Key Players Pharmacovigilance (PV) Outsourcing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Pharmacovigilance (PV) Outsourcing Market Share (2019-2020)
Table 39. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 40. North America Pharmacovigilance (PV) Outsourcing Market Share by Type (2015-2020)
Table 41. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 42. North America Pharmacovigilance (PV) Outsourcing Market Share by Application (2015-2020)
Table 43. Europe Key Players Pharmacovigilance (PV) Outsourcing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Pharmacovigilance (PV) Outsourcing Market Share (2019-2020)
Table 45. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Pharmacovigilance (PV) Outsourcing Market Share by Type (2015-2020)
Table 47. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Pharmacovigilance (PV) Outsourcing Market Share by Application (2015-2020)
Table 49. China Key Players Pharmacovigilance (PV) Outsourcing Revenue (2019-2020) (Million US$)
Table 50. China Key Players Pharmacovigilance (PV) Outsourcing Market Share (2019-2020)
Table 51. China Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 52. China Pharmacovigilance (PV) Outsourcing Market Share by Type (2015-2020)
Table 53. China Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 54. China Pharmacovigilance (PV) Outsourcing Market Share by Application (2015-2020)
Table 55. Japan Key Players Pharmacovigilance (PV) Outsourcing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Pharmacovigilance (PV) Outsourcing Market Share (2019-2020)
Table 57. Japan Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Pharmacovigilance (PV) Outsourcing Market Share by Type (2015-2020)
Table 59. Japan Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Pharmacovigilance (PV) Outsourcing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Pharmacovigilance (PV) Outsourcing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Pharmacovigilance (PV) Outsourcing Market Share (2019-2020)
Table 63. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Share by Type (2015-2020)
Table 65. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Share by Application (2015-2020)
Table 67. India Key Players Pharmacovigilance (PV) Outsourcing Revenue (2019-2020) (Million US$)
Table 68. India Key Players Pharmacovigilance (PV) Outsourcing Market Share (2019-2020)
Table 69. India Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 70. India Pharmacovigilance (PV) Outsourcing Market Share by Type (2015-2020)
Table 71. India Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 72. India Pharmacovigilance (PV) Outsourcing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Pharmacovigilance (PV) Outsourcing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Pharmacovigilance (PV) Outsourcing Market Share (2019-2020)
Table 75. Central & South America Pharmacovigilance (PV) Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Pharmacovigilance (PV) Outsourcing Market Share by Type (2015-2020)
Table 77. Central & South America Pharmacovigilance (PV) Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Pharmacovigilance (PV) Outsourcing Market Share by Application (2015-2020)
Table 79. Accenture Company Details
Table 80. Accenture Business Overview
Table 81. Accenture Product
Table 82. Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 83. Accenture Recent Development
Table 84. C3i Solutions Company Details
Table 85. C3i Solutions Business Overview
Table 86. C3i Solutions Product
Table 87. C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 88. C3i Solutions Recent Development
Table 89. Clintec Company Details
Table 90. Clintec Business Overview
Table 91. Clintec Product
Table 92. Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 93. Clintec Recent Development
Table 94. Covance Company Details
Table 95. Covance Business Overview
Table 96. Covance Product
Table 97. Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 98. Covance Recent Development
Table 99. Deloitte Touche Tohmatsu Limited Company Details
Table 100. Deloitte Touche Tohmatsu Limited Business Overview
Table 101. Deloitte Touche Tohmatsu Limited Product
Table 102. Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 103. Deloitte Touche Tohmatsu Limited Recent Development
Table 104. ELC Group Company Details
Table 105. ELC Group Business Overview
Table 106. ELC Group Product
Table 107. ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 108. ELC Group Recent Development
Table 109. Ergomed Company Details
Table 110. Ergomed Business Overview
Table 111. Ergomed Product
Table 112. Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 113. Ergomed Recent Development
Table 114. iGATE Corporation Business Overview
Table 115. iGATE Corporation Product
Table 116. iGATE Corporation Company Details
Table 117. iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 118. iGATE Corporation Recent Development
Table 119. iMED Global Corporation Company Details
Table 120. iMED Global Corporation Business Overview
Table 121. iMED Global Corporation Product
Table 122. iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 123. iMED Global Corporation Recent Development
Table 124. IQVIA Company Details
Table 125. IQVIA Business Overview
Table 126. IQVIA Product
Table 127. IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 128. IQVIA Recent Development
Table 129. MarksMan Healthcare Company Details
Table 130. MarksMan Healthcare Business Overview
Table 131. MarksMan Healthcare Product
Table 132. MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 133. MarksMan Healthcare Recent Development
Table 134. Medpace Holdings Company Details
Table 135. Medpace Holdings Business Overview
Table 136. Medpace Holdings Product
Table 137. Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 138. Medpace Holdings Recent Development
Table 139. Novartis Company Details
Table 140. Novartis Business Overview
Table 141. Novartis Product
Table 142. Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 143. Novartis Recent Development
Table 144. Oracle Corporation Company Details
Table 145. Oracle Corporation Business Overview
Table 146. Oracle Corporation Product
Table 147. Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 148. Oracle Corporation Recent Development
Table 149. Parexel Company Details
Table 150. Parexel Business Overview
Table 151. Parexel Product
Table 152. Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 153. Parexel Recent Development
Table 154. PharmInvent Company Details
Table 155. PharmInvent Business Overview
Table 156. PharmInvent Product
Table 157. PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 158. PharmInvent Recent Development
Table 159. PrimeVigilance Company Details
Table 160. PrimeVigilance Business Overview
Table 161. PrimeVigilance Product
Table 162. PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 163. PrimeVigilance Recent Development
Table 164. Pure Drug Safety Company Details
Table 165. Pure Drug Safety Business Overview
Table 166. Pure Drug Safety Product
Table 167. Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 168. Pure Drug Safety Recent Development
Table 169. Sciformix Company Details
Table 170. Sciformix Business Overview
Table 171. Sciformix Product
Table 172. Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 173. Sciformix Recent Development
Table 174. SIRO Clinpharm Company Details
Table 175. SIRO Clinpharm Business Overview
Table 176. SIRO Clinpharm Product
Table 177. SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 178. SIRO Clinpharm Recent Development
Table 179. Symogen Company Details
Table 180. Symogen Business Overview
Table 181. Symogen Product
Table 182. Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2015-2020) (Million US$)
Table 183. Symogen Recent Development
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacovigilance (PV) Outsourcing Market Share by Type: 2020 VS 2026
Figure 2. Contract Research Organizations (CROs) Features
Figure 3. Business Process Outsourcing (BPOs) Features
Figure 4. Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2020 VS 2026
Figure 5. Premarketing Clinical Trial Case Studies
Figure 6. Post-marketing Clinical Practice Case Studies
Figure 7. Other Case Studies
Figure 8. Pharmacovigilance (PV) Outsourcing Report Years Considered
Figure 9. Global Pharmacovigilance (PV) Outsourcing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions: 2020 VS 2026
Figure 11. Global Pharmacovigilance (PV) Outsourcing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Pharmacovigilance (PV) Outsourcing Market Share by Players in 2019
Figure 14. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue in 2019
Figure 16. North America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Accenture Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Accenture Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 25. C3i Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. C3i Solutions Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 27. Clintec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Clintec Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 29. Covance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Covance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 31. Deloitte Touche Tohmatsu Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Deloitte Touche Tohmatsu Limited Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 33. ELC Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. ELC Group Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 35. Ergomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Ergomed Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 37. iGATE Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. iGATE Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 39. iMED Global Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. iMED Global Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 41. IQVIA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. IQVIA Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 43. MarksMan Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. MarksMan Healthcare Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 45. Medpace Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Medpace Holdings Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 47. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Novartis Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 49. Oracle Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Oracle Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 51. Parexel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Parexel Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 53. PharmInvent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. PharmInvent Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 55. PrimeVigilance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. PrimeVigilance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 57. Pure Drug Safety Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Pure Drug Safety Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 59. Sciformix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sciformix Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 61. SIRO Clinpharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. SIRO Clinpharm Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs